CLINICAL STUDY
Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry
Alice K. Jacobs, MD, FACC*,
John K. French, PhD, MBChB ,
Jacques Col, MD ,
Lynn A. Sleeper, ScD ,
James N. Slater, MD, FACC||,
Louis Carnendran, MD||,
Jean Boland, MD¶,
Xianjiao Jiang, MS,
Thierry LeJemtel, MD, FACC**,
Judith S. Hochman, MD, FACC|| for the SHOCK Investigators
* Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA
Green Lane Hospital, Auckland, New Zealand
Cliniques Universitaires, Brussels, Belgium
New England Research Institutes, Watertown, Massachusetts, USA
|| St. Luke’s–Roosevelt Hospital, New York, New York, USA
¶ CHR Citadelle, Liège, Belgium
** Albert Einstein College of Medicine, Bronx, New York, USA
Manuscript received February 16, 2000;
revised manuscript received June 19, 2000,
accepted June 20, 2000.
Reprint requests and correspondence: Dr. Alice K. Jacobs, Boston Medical Center, 88 East Newton St., Boston, Massachusetts 02118
alice.jacobs{at}bmc.org
OBJECTIVES
We sought to determine the outcomes of patients with cardiogenic shock (CS) complicating non-ST-segment elevation acute myocardial infarction (MI).
BACKGROUND
Such patients represent a high-risk (ST-segment depression) or low-risk (normal or nonspecific electrocardiographic findings) group for whom optimal therapy, particularly in the setting of shock, is unknown.
METHODS
We assessed characteristics and outcomes of 881 patients with CS due to predominant left ventricular (LV) dysfunction in the SHOCK Trial Registry.
RESULTS
Patients with non-ST-segment elevation MI (n = 152) were significantly older and had significantly more prior MI, heart failure, azotemia, bypass surgery, and peripheral vascular disease than patients with ST-elevation MI (n = 729). On average, the groups had similar in-hospital LV ejection fractions ( 30%), but patients with non-ST-elevation MI had a lower highest creatine kinase and were more likely to have triple-vessel disease. Among patients selected for coronary angiography, the left circumflex artery was the culprit vessel in 34.6% of non-ST-elevation versus 13.4% of ST-elevation MI patients (p = 0.001). Despite having more recurrent ischemia (25.7% vs. 17.4%, p = 0.058), non-ST-elevation patients underwent angiography less often (52.6% vs. 64.1%, p = 0.010). The proportion undergoing revascularization was similar (36.8% for non-ST-elevation vs. 41.9% ST-elevation MI, p = 0.277). In-hospital mortality also was similar in the two groups (62.5% for non-ST-elevation vs. 60.4% ST-elevation MI). After adjustment, ST-segment elevation MI did not independently predict in-hospital mortality (odds ratio, 1.30; 95% confidence interval, 0.83 to 2.02; p = 0.252).
CONCLUSIONS
Patients with CS and non-ST-segment elevation MI have a higher-risk profile than shock patients with ST-segment elevation, but similar in-hospital mortality. More recurrent ischemia and less angiography represent opportunities for earlier intervention, and early reperfusion therapy for circumflex artery occlusion should be considered when non-ST-elevation MI causes CS.
|
Abbreviations and Acronyms
| | CHF | = congestive heart failure | | CK(-MB) | = creatine kinase (-MB) | | CS | = cardiogenic shock | | ECG | = electrocardiogram, electrocardiographic | | LBBB | = left bundle branch block | | LV | = left ventricular, left ventricle | | MI | = myocardial infarction | | SHOCK | = SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? |
|
This article has been cited by other articles:
|
|
|
|
 
R. V. Jeger, D. Radovanovic, P. R. Hunziker, M. E. Pfisterer, J.-C. Stauffer, P. Erne, P. Urban, and for the AMIS Plus Registry Investigators
Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock
Ann Intern Med,
November 4, 2008;
149(9):
618 - 626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. C. Dixon IV, T. Y. Wang, D. Dai, K. A. Shunk, E. D. Peterson, M. T. Roe, and National Cardiovascular Data Registry
Anatomic Distribution of the Culprit Lesion in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Findings From the National Cardiovascular Data Registry
J. Am. Coll. Cardiol.,
October 14, 2008;
52(16):
1347 - 1348.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Singh, J. White, D. Hasdai, P. K. Hodgson, P. B. Berger, E. J. Topol, R. M. Califf, and D. R. Holmes Jr
Long-Term Outcome and its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock: Insights From the GUSTO-I Trial
J. Am. Coll. Cardiol.,
October 30, 2007;
50(18):
1752 - 1758.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zannad, A. Mebazaa, Y. Juilliere, A. Cohen-Solal, L. Guize, F. Alla, P. Rouge, P. Blin, M.-H. Barlet, L. Paolozzi, et al.
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study
Eur J Heart Fail,
November 1, 2006;
8(7):
697 - 705.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Duvernoy and E. R. Bates
Management of Cardiogenic Shock Attributable to Acute Myocardial Infarction in the Reperfusion Era
J Intensive Care Med,
July 1, 2005;
20(4):
188 - 198.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al.
Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Eur. Heart J.,
April 2, 2005;
26(8):
804 - 847.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Urban
The veteran and the rookie
Eur. Heart J.,
January 1, 2005;
26(1):
1 - 2.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Hamaad, G. Y.H. Lip, and R. J. MacFadyen
Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?
Eur J Heart Fail,
October 1, 2004;
6(6):
683 - 686.
[Full Text]
[PDF]
|
|
|
|
